Literature DB >> 16934375

Aerosol measles vaccination in macaques: preclinical studies of immune responses and safety.

Rik L de Swart1, Thijs Kuiken, Jorge Fernandez-de Castro, Mark J Papania, John V Bennett, José L Valdespino, Phil Minor, Clyde L Witham, Selma Yüksel, Helma Vos, Geert van Amerongen, Albert D M E Osterhaus.   

Abstract

The comparative efficacy and safety of measles vaccination via the aerosol route versus subcutaneous injection has not been fully resolved. We vaccinated cynomolgus monkeys (Macaca fascicularis) with the live-attenuated Edmonston-Zagreb measles virus (MV) vaccine and compared different routes of administration in the immunocompetent and the immunocompromised host. Immunogenicity and protective efficacy of aerosol vaccination using devices similar to those previously used in humans were comparable to those in animals vaccinated by injection. No evidence for a safety hazard associated with the route of vaccination was detected. The results of this study support further clinical evaluation of aerosol vaccination for measles.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16934375     DOI: 10.1016/j.vaccine.2006.05.125

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  9 in total

1.  Successful respiratory immunization with dry powder live-attenuated measles virus vaccine in rhesus macaques.

Authors:  Wen-Hsuan Lin; Diane E Griffin; Paul A Rota; Mark Papania; Stephen P Cape; David Bennett; Brian Quinn; Robert E Sievers; Charles Shermer; Kenneth Powell; Robert J Adams; Steven Godin; Scott Winston
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-31       Impact factor: 11.205

2.  Unique cellular and humoral immunogenicity profiles generated by aerosol, intranasal, or parenteral vaccination in rhesus macaques.

Authors:  Diane L Bolton; Kaimei Song; Georgia D Tomaras; Srinivas Rao; Mario Roederer
Journal:  Vaccine       Date:  2016-12-29       Impact factor: 3.641

3.  In vivo tropism of attenuated and pathogenic measles virus expressing green fluorescent protein in macaques.

Authors:  Rory D de Vries; Ken Lemon; Martin Ludlow; Stephen McQuaid; Selma Yüksel; Geert van Amerongen; Linda J Rennick; Bert K Rima; Albert D M E Osterhaus; Rik L de Swart; W Paul Duprex
Journal:  J Virol       Date:  2010-02-24       Impact factor: 5.103

4.  Measles virus suppresses RIG-I-like receptor activation in dendritic cells via DC-SIGN-mediated inhibition of PP1 phosphatases.

Authors:  Annelies W Mesman; Esther M Zijlstra-Willems; Tanja M Kaptein; Rik L de Swart; Meredith E Davis; Martin Ludlow; W Paul Duprex; Michaela U Gack; Sonja I Gringhuis; Teunis B H Geijtenbeek
Journal:  Cell Host Microbe       Date:  2014-07-09       Impact factor: 21.023

Review 5.  An evaluation of respiratory administration of measles vaccine for prevention of acute lower respiratory infections in children.

Authors:  Daisy Higginson; Evropi Theodoratou; Harish Nair; Tanvir Huda; Lina Zgaga; Suresh S Jadhav; Saad B Omer; Igor Rudan; Harry Campbell
Journal:  BMC Public Health       Date:  2011-04-13       Impact factor: 3.295

6.  Needle-free delivery of measles virus vaccine to the lower respiratory tract of non-human primates elicits optimal immunity and protection.

Authors:  Rik L de Swart; Rory D de Vries; Linda J Rennick; Geert van Amerongen; Stephen McQuaid; R Joyce Verburgh; Selma Yüksel; Alwin de Jong; Ken Lemon; D Tien Nguyen; Martin Ludlow; Albert D M E Osterhaus; W Paul Duprex
Journal:  NPJ Vaccines       Date:  2017-08-01       Impact factor: 7.344

7.  Comparison of Immunogenicity and Protective Efficacy of PPR Live Attenuated Vaccines (Nigeria 75/1 and Sungri 96) Administered by Intranasal and Subcutaneous Routes.

Authors:  Mana Mahapatra; M Selvaraj; Satya Parida
Journal:  Vaccines (Basel)       Date:  2020-04-06

Review 8.  Measles studies in the macaque model.

Authors:  R L de Swart; R L DeSwart
Journal:  Curr Top Microbiol Immunol       Date:  2009       Impact factor: 4.291

Review 9.  Macaque models of human infectious disease.

Authors:  Murray B Gardner; Paul A Luciw
Journal:  ILAR J       Date:  2008
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.